Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1976 Feb;3(1 Suppl 1):42–44. doi: 10.1111/j.1365-2125.1976.tb03711.x

The biochemical evaluation of psychotropic drugs.

A V Mackay
PMCID: PMC2958716  PMID: 973946

Full text

PDF
42

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashcroft G. W., Blackburn I. M., Eccleston D., Glen A. I., Hartley W., Kinloch N. E., Lonergan M., Murray L. G., Pullar I. A. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness. Psychol Med. 1973 Aug;3(3):319–325. doi: 10.1017/s0033291700049606. [DOI] [PubMed] [Google Scholar]
  2. Bird E. D., Mackay A. V., Rayner C. N., Iversen L. L. Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea. Lancet. 1973 May 19;1(7812):1090–1092. doi: 10.1016/s0140-6736(73)90398-x. [DOI] [PubMed] [Google Scholar]
  3. Chase T. N., Schnur J. A., Gordon E. K. Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders. Neuropharmacology. 1970 May;9(3):265–268. doi: 10.1016/0028-3908(70)90075-4. [DOI] [PubMed] [Google Scholar]
  4. Davidson L., Lloyd K., Dankova J., Hornykiewicz O. L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions. Experientia. 1971 Sep 15;27(9):1048–1049. doi: 10.1007/BF02138873. [DOI] [PubMed] [Google Scholar]
  5. Hattori T., McGeer P. L., Fibiger H. C., McGeer E. G. On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies. Brain Res. 1973 May 17;54:103–114. doi: 10.1016/0006-8993(73)90037-1. [DOI] [PubMed] [Google Scholar]
  6. Horn A. S., Snyder S. H. Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proc Natl Acad Sci U S A. 1971 Oct;68(10):2325–2328. doi: 10.1073/pnas.68.10.2325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kim J. S., Bak I. J., Hassler R., Okada Y. Role of -aminobutyric acid (GABA) in the extrapyramidal motor system. 2. Some evidence for the existence of a type of GABA-rich strio-nigral neurons. Exp Brain Res. 1971;14(1):95–104. doi: 10.1007/BF00234913. [DOI] [PubMed] [Google Scholar]
  8. Lloyd K. G., Hornykiewicz O. L-glutamic acid decarboxylase in Parkinson's disease: effect of L-dopa therapy. Nature. 1973 Jun 29;243(5409):521–523. doi: 10.1038/243521a0. [DOI] [PubMed] [Google Scholar]
  9. Maas J. W., Fawcett J. A., Dekirmenjian H. Catecholamine metabolism, depressive illness, and drug response. Arch Gen Psychiatry. 1972 Mar;26(3):252–262. doi: 10.1001/archpsyc.1972.01750210060012. [DOI] [PubMed] [Google Scholar]
  10. Mackay A. V. The long-term regulation of tyrosine hydroxylase activity in cultured sympathetic ganglia: role of ganglionic noradrenaline content. Br J Pharmacol. 1974 Aug;51(4):509–520. doi: 10.1111/j.1476-5381.1974.tb09669.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Miller R. J., Iversen L. L. Effect of chlorpromazine and some of its metabolites on the dopamine-sensitive adenylate cyclase of rat brain striatum. J Pharm Pharmacol. 1974 Feb;26(2):142–144. doi: 10.1111/j.2042-7158.1974.tb09243.x. [DOI] [PubMed] [Google Scholar]
  12. Modified amine hypothesis for the aetiology of affective illness. Lancet. 1972 Sep 16;2(7777):573–577. [PubMed] [Google Scholar]
  13. Sakalis G., Curry S. H., Mould G. P., Lader M. H. Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):931–946. doi: 10.1002/cpt1972136931. [DOI] [PubMed] [Google Scholar]
  14. Schildkraut J. J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry. 1965 Nov;122(5):509–522. doi: 10.1176/ajp.122.5.509. [DOI] [PubMed] [Google Scholar]
  15. van Praag H. M., Korf J. A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients. Biol Psychiatry. 1971;3(2):105–112. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES